Activity of blood plasma adenosine deaminase and mononuclear cell lysates in pulmonary tuberculosis patients with different levels of resistance to anti-tuberculosis agents
https://doi.org/10.21292/2075-1230-2015-0-4-58-61
Abstract
The purpose of this research is to investigate the activity of adenosine deaminase and its isozymes in pulmonary tuberculosis patients depending on resistance of mycobacteria to anti-tuberculosis agents.
It has been found out that the ADA level on blood plasma is higher in the patients with drug resistant mycobacteria, in the patients with multiple/extensive drug resistant mycobacteria (M/XDR) insignificant increase on enzyme activity has been observed, which can be the evidence of the immune system activity suppression.
It has been shown that in case of drug susceptible pulmonary tuberculosis the increase of general ADA activity in blood plasma is due to increase of activity in both isozymes and in patients with M/XDR mycobacteria the increase of enzyme activity happens due to the increase in ADA2.
About the Authors
O. O. Yanovich
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus
Minsk
Belarus
Minsk
L. P. Titov
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus
Minsk
Belarus
Minsk
M. I. Dus'mikeyeva
Republican Scientific and Practical Center of Pulmonology and Tuberculosis
Belarus
Minsk
Belarus
Minsk
N. S. Shpakovskaya
Republican Scientific and Practical Center of Pulmonology and Tuberculosis
Belarus
Minsk
Belarus
Minsk
References
1. Baganha M., Pego A., Lima M.A. et. al. Serum and pleural adenosine deaminase: Correlation with lymphocytic populations. Chest, 1990, vol. 97, no. 3, pp. 605-610.
2. Bhargava D.K., Grupta M., Nijhown S. et al. Adenosine deaminase (ADA) in peritoneal tuberculosis: diagnostic value in ascitic fluid and serum. Tubercle, 1990, vol. 71, no. 2, pp. 121-126.
3. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide. MMWR Morb. Mortal. Wkly. Rep., 2006, vol. 55, no. 11, pp. 301-305.
4. Martinez-Vasquez J.M., Ribera E., Ocana I. et al. Adenosine deaminase activity in tuberculous pericarditis. Thorax, 1986, vol. 41, no. 11, pp. 88-89.
5. Ribera E., Martinez-Vasquez J.M., Ocana I. et al. Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow up tuberculous meningitis in adults. J. Infect. Dis., 1987, vol. 155, no. 4, pp. 603-607.
6. Shammary F.J. Adenosine deaminase activity in serum and pleural effusions of tuberculosis and non-tuberculous patients. Biochem. Mol. Biol. Int., 1997, vol. 43, no. 4, pp. 763-779.
7. Shore A., Dosch H.M., Gelfond E.W. Role of adenosine deaminase in the early stages of precursor T cell maturation. Clin. Exp. Immunol., 1981, vol. 44, no. 1, pp. 152-155.
8. Surkova L., Horevich H.L., Titov L.P. et al. A study on demographic characteristics of drug resistant Mycobacterium tuberculosis isolates in Belarus. Int. J. Micobac., 2012, vol. 1, no. 2, pp. 75-81.
9. Valdes L., Jose E.S., Alvarez D. et al. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role and relevance to the origin of increased ADAin tuberculosis pleurisy. Eur. Respir. J., 1996, vol. 9. pp. 747-751.
10. World Health Organization (WHO). Extensively drug-resistant tuberculosis (XDR.TB): recommendations for prevention and control. Weekly Epidemiol Record. 2006, vol. 81. pp. 430-432.
Review
For citations:
Yanovich O.O., Titov L.P., Dus'mikeyeva M.I., Shpakovskaya N.S. Activity of blood plasma adenosine deaminase and mononuclear cell lysates in pulmonary tuberculosis patients with different levels of resistance to anti-tuberculosis agents. Tuberculosis and Lung Diseases. 2015;(4):58-61. (In Russ.) https://doi.org/10.21292/2075-1230-2015-0-4-58-61
Views:
2631
Email this article 